Please assess the completion status of the following clinical trial:

Trial Title: Combination Nicotine Replacement for Alcoholic Smokers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Males and females at least 18 years old.~* English speaking.~* Meets criteria for alcohol dependence or alcohol abuse.~* Must complete an alcohol detoxification program prior to entering the study.~* Currently smoking 15 or more cigarettes per day and have at least a 3 year history of smoking.~* Have a current desire to stop smoking and stop drinking.~* Willing to complete followup assessments up to 12 months after treatment.~* Willing to provide names of 2 people who can help locate the subject at followup and the name of one person who can verify information about alcohol and tobacco use.~* One person per household.~Exclusion Criteria:~* Allergy to nicotine patch or nicotine gum.~* Weigh less than 100 pounds.~* Use other nicotine products, such as cigars, pipes or smokeless tobacco.~* Severe skin disorder.~* Active peptic ulcer.~* Active joint disease.~* Heart attack within 3 months prior to entering the study.~* Pregnant or breastfeeding female who are not on birth control.~* Currently taking medication to treat alcoholism or smoking, such as naltrexone, disulfiram or bupropion.~* Poor vision or hearing that would interfere with using a cell phone.~* Lack of transportation to the treatment site or live at least one hour from the treatment site.~* Homeless.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nicotine patch plus placebo gum (Type: PLACEBO_COMPARATOR): Subjects in both arms were instructed to use one 21-mg (Nicoderm CQ®) nicotine patch daily for 8 weeks followed by one 14-mg patch daily for 2 weeks, then followed by one 7-mg patch daily for 2 weeks, for a total of 12 weeks of nicotine patch therapy. Placebo gum was given for ad libitum use, with encouragement to use at least six pieces per day, up to a maximum of 20 pieces per day. The placebo gum (manufactured by Fertin Pharma A/S, Vejle, Denmark) contained 2.6% cayenne pepper to simulate the taste of nicotine. Use of the gum was encouraged for 24 weeks.
- Nicotine patch plus active gum (Type: ACTIVE_COMPARATOR): Subjects in both arms were instructed to use one 21-mg (Nicoderm CQ®) nicotine patch daily for 8 weeks followed by one 14-mg patch daily for 2 weeks, then followed by one 7-mg patch daily for 2 weeks, for a total of 12 weeks of nicotine patch therapy. Nicotine gum (2 mg uncoated mint Nicorette®) was given for ad libitum use, with encouragement to use at least six pieces per day, up to a maximum of 20 pieces per day. Use of the gum was encouraged for 24 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).